Breast Cancer Clinical Trials

Showing 2001-2020 of 4,817 trials

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.

NCT04395989

This is a Phase II, open-label, randomized controlled umbrella trial evaluating the efficacy and safety of multiple targeted treatment in patients with metastaticTNBC.

TNBC - Triple-Negative Breast Cancer

Fudan University139 participantsStarted Jul 2020

Shanghai, Shanghai Municipality, China

WITHDRAWNEARLY Phase 1

A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer

NCT05465590

The study will evaluate the pharmacokinetics (PK) and safety of a single intravenous (IV) dose of 0.3 mg/kg MB1707 in patients with advanced cancers.

Advanced Solid TumorBreast CancerNon Small Cell Lung Cancer+2 more

Mainline Biosciences, Inc.Started Dec 2022

An Umbrella Trial Based on Molecular Pathway for Patients With Metastatic TNBC.

A Phase 1 Study to Evaluate Paclitaxel Conjugated CXC Receptor 4 Antagonist (MB1707) in Patients With Advanced Cancer

Related Searches

A Study of MGD013 in Patients With Unresectable or Metastatic Neoplasms

Physical Training and Cancer-a Multicenter Clinical Trial

Communication in Breast Cancer Care

Detection of Breast Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

Avoiding Low-value Treatments in Older Women With Early-stage Breast Cancer: Piloting a Patient Decision Aid

A Study of [225Ac]-FPI-1966 in Participants With Advanced Solid Tumours

CB-103 Plus NSAI In Luminal Advanced Breast Cancer

Trial of Nivolumab With Chemotherapy as Neoadjuvant Treatment in Inflammatory Breast Cancer (IBC)

SILibinin in NSCLC and BC Patients With Single Brain METastasis (SILMET)

Evaluation of the Impact of the Use of Hypnotherapy Performed by a Virtual Reality Toolalong the Care Pathway of Patients Undergoing Breast Cancer Treatment.

Investigation of Ultrasound Imaging and Spectroscopy for Characterizing Breast Masses

Digoxin Induced Dissolution of CTC Clusters

Novel MRI-Guided Ultrasound Stimulated Microbubble Radiation Treatment for Patients With Chest-wall and Breast Cancer

Impact of a Predictive Model on Sentinel Lymph Node Biopsy in Initially Lymph Node-positive, HER2-positive Breast Cancer

Noninvasive Assessment of Lymphedema Among Breast Cancer Survivors

Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients

English Mammography Screening Outcomes by Age, Frequency and Test Threshold

Using Color Doppler US Artifact to Identify Tumor Markers